IP Library Granted Patent US 7,709,261
Granted Patent B2
US 7,709,261 · App. 11/773,408 · Granted May 4, 2010

Recycling system for manipulation of intracellular NADH availability

Assignee: Rice University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,709,261
App. No.
11/773,408
Granted
May 4, 2010
Kind
B2
Abstract

The present invention describes a novel recombinant NADH recycling system that is used as a process for producing reduced compounds. In a specific embodiment, the reduced compounds include ethanol, succinate, lactate, a vitamin, a pharmaceutical and a biodegraded organic molecule. The NADH recycling system effects metabolic flux of reductive pathways in aerobic and anaerobic environments.

Claims (9)

1. A method of producing an NADH dependent product comprising:

a) culturing an engineered cell comprising a recombinant NADH-recycling system comprising a native cofactor-independent formate dehydrogenase genetically engineered to reduce its activity as compared with a wild type cell, and an expression construct comprising an expressible gene encoding a heterologous NAD+-dependent formate dehydrogenase (FDH) that increases the enzymatiac activity of NAD+-dependent FDH activity in said cell as compared with a wild type cell, wherein said FDH converts NAD+ to NADH in the presence of formate;

b) inducing production of an NADH dependent product; and

c) isolating the NADH dependent product.

2. The method of claim 1 , wherein said NADH dependent product is selected from the group consisting of an amino acid, organic acid, hydroxy acid, ester, alcohol, vitamin, antimicrobial, pharmaceutical, polypeptide, biopolymer, mineral, or biodegraded organic compound.

3. The method of claim 1 , wherein said engineered cell is cultured with formate.

4. The method of claim 1 , wherein said engineered cell is cultured with at least about 100 mM formate.

5. The method of claim 1 , wherein said engineered cell is cultured under aerobic conditions.

6. The method of claim 1 , wherein said engineered cell is cultured under anaerobic conditions.

Assignments (1)
CONFIRMATORY LICENSE Recorded May 24, 2012
From: RICE UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 028274/0454 →
Continuity (1)
Related Publication 20080009034A1 · Jan 10, 2008